Daniel S. Palacios

Statistics

Publications

Citations

915

H-Index

Active since

2007

Affiliations

University of Illinois Urbana-Champaign(Current)

Novartis (United States)

Howard Hughes Medical Institute

Daniel S. Palacios is an author at University of Illinois Urbana-Champaign specializing in drug discovery, medicinal chemistry, and antifungal agents.

ORCID

Publications per year

2007–2019

Publications

Amphotericin primarily kills yeast by simply binding ergosterol

Kaitlyn Gray, Daniel S. Palacios, Ian Dailey et al. · Proceedings of the National Academy of Sciences · 2012 · 603 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities

Daniel S. Palacios, Ian Dailey, David M. Siebert et al. · Proceedings of the National Academy of Sciences · 2011 · 139 citations

Life Sciences, Biochemistry, Molecular Biology +17

A Post-PKS Oxidation of the Amphotericin B Skeleton Predicted to be Critical for Channel Formation Is Not Required for Potent Antifungal Activity

Daniel S. Palacios, Thomas M. Anderson, Martin D. Burke · Journal of the American Chemical Society · 2007 · 99 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +15

Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody–Drug Conjugates

Alexei S. Karpov, Tinya J. Abrams, Suzanna Clark et al. · ACS Medicinal Chemistry Letters · 2018 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen

Daniel S. Palacios, Erik L. Meredith, Toshio Kawanami et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 17 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

1–5 of 6